QBJ
- 产品代码
- QBJ
- 器械名称
- Integrated Continuous Glucose Monitoring System, Factory Calibrated
- 管理类别
- 第 2 类(Class II)
- 21 CFR 条款
- 21 CFR 862.1355
- FDA 专业组
- Clinical Chemistry
- 上市路径
- 需提交 510(k) 上市前通告
- 该代码近三年的 510(k)
- 7 件
- 其中 Summary 已存档
- 6 份,可直接下载
- FDA 历史累计 510(k)
- 18 件(全部年份;本站只收录近三年的明细)
FDA 分类定义
An integrated continuous glucose monitoring system (iCGM) is intended to automatically measure glucose in bodily fluids continuously or frequently for a specified period of time. iCGM systems are designed to reliably and securely transmit glucose measurement data to digitally connected devices, including automated insulin dosing systems, and are intended to be used alone or in conjunction with these digitally connected medical devices for the purpose of managing a disease or condition related to glycemic control.
该代码近三年的 510(k)(7 件)
| 510(k) 号 | 批准日期 | 申请人 | 器械名称 | 摘要 |
|---|---|---|---|---|
| K261402 | 2026-06-08 | Dexcom, Inc. | Dexcom G7 Continuous Glucose Monitoring System;Dexco | |
| K253737 | 2026-02-03 | Dexcom, Inc. | Dexcom G7 Continuous Glucose Monitoring (CGM) System | |
| K253710 | 2025-12-17 | Dexcom, Inc. | Dexcom G7 Continuous Glucose Monitoring (CGM) System | |
| K243214 | 2025-04-09 | Dexcom, Inc. | Dexcom G7 15 Day Continuous Glucose Monitoring Syste | |
| K240902 | 2024-04-23 | Dexcom, Inc. | Dexcom G7 Continuous Glucose Monitoring System | |
| K233537 | 2024-04-23 | Abbott Diabetes Care, Inc. | FreeStyle Libre 3 Continuous Glucose Monitoring Syst | FDA |
| K234133 | 2024-02-26 | Dexcom, Inc. | Dexcom G7 Continuous Glucose Monitoring System |
FDA 官方分类页: QBJ
分类与上市路径以 FDA 现行公告为准。本页数据来自 openFDA(CC0 公有领域),不构成注册策略建议。